Dan Mulhern

We present an index that gives a transparent, quantifiable measure of leading indicators to help insurers and investors anticipate shifts in medical costs.

Using diabetes as an example, we present the potential opportunity to use social impact bonds to test new chronic disease prevention interventions.

What are the actual effects of deferred and foregone care on total spending for the commercially insured population?